DIANA SCHULTZ: Open Payments
NPI 1073767612 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$943 in 12 payments from 8 companies in 2025. Trend: 2023 $142 · 2024 $20 · 2025 $943
Food & beverage: $943
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $220 |
| Amgen Inc. | 1 | $146 |
| Teva Pharmaceuticals USA, Inc. | 1 | $137 |
| SANOFI-AVENTIS U.S. LLC | 1 | $133 |
| Novo Nordisk Inc | 1 | $108 |
| Janssen Biotech, Inc. | 1 | $102 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $83 |
| Merck Sharp & Dohme LLC | 1 | $14 |
Products named: TZIELD, BREZTRI, Ozempic, FASENRA, TREMFYA, XIFAXAN, ZERBAXA.
Industry payments across TN — which companies pay providers there.
